The 'OAinject' consortium, in which Peter van der Kraan is involved as one of the Work Package leaders, received the NWO 'Perspectief' grant to develop new diagnostic tools that determine exactly what form of osteoarthritis someone has to enable tailor-made treatments. In addition, the researchers are working on innovative ways to administer medicines in the joint over a long period, gradually, and locally via a depot. In this way, the consortium wants to ensure that patients can maintain an active lifestyle that helps prevent other conditions such as cardiovascular disease and dementia.
More than 1.5 million Dutch people suffer from osteoarthritis – a rheumatic disease of the joints that causes pain, stiffness and difficulty moving. Since osteoarthritis is a condition that mainly occurs in the elderly, the number of patients will only increase due to the aging of the population. There is currently no adequate treatment.
The NWO 'Perspectief' program challenges researchers to form consortia with the business community and social organisations. Together they work on technological innovations with social impact and the creation of economic opportunities for the Netherlands, thereby contributing to the mission-driven Top Sectors and Innovation Policy. A total of 32 million euros is available for the seven consortia within the program. 'OAInject' is one of those consortia.
Related news items
Joint research in regional hospitals New research projects from promotion fund
22 November 2022Four research projects have been honored in the promotion fund of the Radboudumc and four regional hospitals. The research projects, which are a collaboration between CWZ, Jeroen Bosch Hospital, Rijnstate, Sint Maartenskliniek and the Radboudumc will receive a contribution of 240,000 euros.
read moreTrained immunity’s role in kidney disease
17 November 2022Researcher(s) Jordi Ochando of the Icahn School of Medicine at Mount Sinai in New York and Raphaël Duivenvoorden of the Department of Nephrology at Radboudumc explain how trained immunity can have detrimental effects in kidney disease and transplantation.
read more